Safety and pharmacokinetics of urtoxazumab, a humanized monoclonal antibody, against Shiga-like toxin 2 in healthy adults and in pediatric patients infected with Shiga-like toxin-producing Escherichia coli.
López EL, Contrini MM, Glatstein E, González Ayala S, Santoro R, Allende D, Ezcurra G, Teplitz E, Koyama T, Matsumoto Y, Sato H, Sakai K, Hoshide S, Komoriya K, Morita T, Harning R, Brookman S.
López EL, et al. Among authors: contrini mm.
Antimicrob Agents Chemother. 2010 Jan;54(1):239-43. doi: 10.1128/AAC.00343-09. Epub 2009 Oct 12.
Antimicrob Agents Chemother. 2010.
PMID: 19822704
Free PMC article.
Clinical Trial.